Miriam González's Journey with AI in Breast Cancer Treatment
In 2021, 35-year-old Miriam González from Murcia sought medical attention due to breast bleeding. She was reassured that everything was normal. However, by 2024, she received a grim diagnosis: stage four metastatic breast cancer. Initially, González struggled with the overwhelming feeling that her time was limited. “I thought that the diagnosis was an immediate sentence, that I had days or weeks left,” she noted. Over time, she began to perceive her situation differently, focusing on chronicity and quality of life.
The Role of Artificial Intelligence
To navigate her diagnosis, González turned to Perplexity, an artificial intelligence (AI) search engine. “My engineering part then emerged,” she shared. Her cancer diagnosis included a rare tumor subtype with neuroendocrine differentiation, which standard clinical guidelines typically overlook. AI became instrumental for her, assisting in organizing complex information and converting her diagnosis into actionable decisions.
As AI technology becomes increasingly integrated into healthcare, millions of users are relying on it for various purposes, from medication inquiries to medical advice. However, experts caution against over-reliance, as AI may be most effective during later stages of diagnosis, according to Mark Succi, a health innovation director at Mass General Brigham and an associate professor at Harvard. He emphasized that while AI shows promise in refining diagnoses, it might struggle in establishing initial diagnostic frameworks.
AI Usage Trends in Health Queries
An analysis of popular AI models demonstrated that half of the health information provided lacks scientific validity, raising concerns about patient safety. Nevertheless, a recent survey revealed that one in four Americans consults chatbots for health advice, often pursuing rapid answers or supplementary information prior to medical appointments. A significant number, particularly low-income individuals, resort to AI as a substitute for direct medical consultations due to financial constraints.
González's journey differed as she engaged actively with her medical team. “I have been lucky enough to find a team that includes me. They listen to me and read the evidence I provide,” she shared. By harnessing AI, she gained access to critical data, clinical trials, and relevant language that enabled her to present a well-informed case to her oncologists.
Collaboration with AI Experts
To further her research, González collaborated with Javi López, an AI specialist from Murcia and a co-founder of Magnific. Together, they shared their case on social media, where it gained widespread attention. López utilized advanced AI systems, including ChatGPT Pro+ Extended and Claude Opus 4.6 MAX, to enhance their understanding of her situation.
López highlighted the need for efficient AI utilization: “I converted González's medical history into a text document to centralize all the information.” He then created a two-thousand-word prompt designed to consult AI as if it were a “multidisciplinary tumor committee.”
Challenges and Future Directions
Exploring the complexities of AI in healthcare requires careful consideration. López expressed optimism about the potential for AI to streamline patient histories, allowing for easier access to vital medical information. While companies like OpenAI are in the early stages of developing health-focused AI platforms, González emphasized the necessity for equitable access to these advanced technologies.
Both González and López's experiences illustrate the invaluable guidance AI can provide in rare medical circumstances. However, it also raises concerns about the disparities in technology and resources available to patients. The conversation around AI's role in healthcare is evolving, with experts urging doctors to incorporate patient research into consultations rather than dismiss it.
González's case exemplifies how AI can reshape patient experiences in healthcare, suggesting a gradual transformation in medical practices as AI becomes a recognized asset in patient empowerment.
